Tonix Pharmaceuticals Files 8-K
Ticker: TNXP · Form: 8-K · Filed: Jul 2, 2025 · CIK: 1430306
Sentiment: neutral
Topics: corporate-update, filing
Related Tickers: TNXP
TL;DR
TNXP filed an 8-K on July 2nd, updating corporate info. Offices in NJ.
AI Summary
Tonix Pharmaceuticals Holding Corp. filed an 8-K on July 2, 2025, reporting on other events and financial statements. The filing indicates the company's principal executive offices are located at 26 Main Street, Suite 101, Chatham, New Jersey 07928, with a business phone number of (862) 799-8. The company was formerly known as Tamandare Explorations Inc. before a name change on March 20, 2008.
Why It Matters
This 8-K filing provides updated corporate information and signals ongoing regulatory compliance for Tonix Pharmaceuticals Holding Corp.
Risk Assessment
Risk Level: low — This filing is a routine corporate update and does not appear to contain significant new financial or operational risks.
Key Players & Entities
- Tonix Pharmaceuticals Holding Corp. (company) — Registrant
- July 2, 2025 (date) — Date of report
- 26 Main Street, Suite 101, Chatham, New Jersey 07928 (location) — Principal executive offices
- (862) 799-8 (phone_number) — Business phone number
- Tamandare Explorations Inc. (company) — Former company name
- March 20, 2008 (date) — Date of name change
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is for a Current Report, indicating it reports on other events and includes financial statements and exhibits.
Where are Tonix Pharmaceuticals Holding Corp.'s principal executive offices located?
The principal executive offices are located at 26 Main Street, Suite 101, Chatham, New Jersey 07928.
What was the company's former name?
The company was formerly known as Tamandare Explorations Inc.
When did the company change its name?
The date of the name change was March 20, 2008.
What is the registrant's telephone number?
The registrant's telephone number, including area code, is (862) 799-8.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 2, 2025 regarding Tonix Pharmaceuticals Holding Corp. (TNXP).